BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33412949)

  • 1. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
    Chang CC; Hayase E; Jenq RR
    Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
    Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
    Front Immunol; 2021; 12():692225. PubMed ID: 34220852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
    Fujiwara H
    Front Immunol; 2021; 12():703298. PubMed ID: 34512627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.
    Yazdandoust E; Hajifathali A; Roshandel E; Zarif MN; Pourfathollah AA; Parkhideh S; Mehdizadeh M; Amini-Kafiabad S
    Transpl Immunol; 2023 Jun; 78():101836. PubMed ID: 37037266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
    Khuat LT; Le CT; Pai CS; Shields-Cutler RR; Holtan SG; Rashidi A; Parker SL; Knights D; Luna JI; Dunai C; Wang Z; Sturgill IR; Stoffel KM; Merleev AA; More SK; Maverakis E; Raybould HE; Chen M; Canter RJ; Monjazeb AM; Dave M; Ferrara JLM; Levine JE; Longo DL; Abedi M; Blazar BR; Murphy WJ
    Sci Transl Med; 2020 Nov; 12(571):. PubMed ID: 33239390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
    Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
    J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
    Daoud-Asfour H; Henig I; Ghersin I; Rakedzon S; Stern A; Pitashny M; Zuckerman T; Bar-Yoseph H
    Transplant Cell Ther; 2022 Mar; 28(3):168.e1-168.e8. PubMed ID: 34954293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
    Henig I; Yehudai-Ofir D; Zuckerman T
    Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Wang S; Yue X; Zhou H; Chen X; Chen H; Hu L; Pan W; Zhao X; Xiao H
    Ann Hematol; 2023 Dec; 102(12):3555-3566. PubMed ID: 37770617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic Profiling of the Ocular Surface Microbiome in Patients After Allogeneic Hematopoietic Stem Cell Transplantation.
    Li J; Liang Q; Huang F; Liao Y; Zhao W; Yang J; Wen X; Li X; Chen T; Guo S; Liang J; Wei L; Liang L
    Am J Ophthalmol; 2022 Oct; 242():144-155. PubMed ID: 35551905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota-related effects on graft-versus-host disease.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
    Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
    Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
    Front Immunol; 2021; 12():757836. PubMed ID: 34712243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.